Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Ezetimibe 10 mg Tablets in Healthy Thai Volunteers
TCTR20210608006Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ezetimibe in hypercholesterolemia (2 arms), sponsored by International Bio Service. Primary endpoint: Primary pharmacokinetic parameters. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on TCTR20210608006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210608006.